Vanishing pulmonary oedema, a visual delight!

portant prognostic predictor in patients with congestive heart failure. J Am Coll Cardiol 1998;31:391–398. 38. Colombo PC, Banchs JE, Celaj S, Talreja A, Lachmann J, Malla S, DuBois NB, Ashton AW, Latif F, Jorde UP, Ware JA, LeJemtel TH. Endothelial cell activation in patients with decompensated heart failure. Circulation 2005;111:58–62. 39. Silverstein RL, Febbraio M. Cd36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior. Sci Signal 2009;2:re3. 40. Zirlik A, Bavendiek U, Libby P, MacFarlane L, Gerdes N, Jagielska J, Ernst S, Aikawa M, Nakano H, Tsitsikov E, Schonbeck U. Traf-1, -2, -3, -5, and -6 are induced in atherosclerotic plaques and differentially mediate proinflammatory functions of cd40l in endothelial cells. Arterioscler Thromb Vasc Biol 2007;27: 1101–1107. 41. Sun D, Novotny M, Bulek K, Liu C, Li X, Hamilton T. Treatment with il-17 prolongs the half-life of chemokine cxcl1 mRNA via the adaptor traf5 and the splicing-regulatory factor sf2 (asf). Nat Immunol 2011;12:853–860. 42. Barlera S, Tavazzi L, Franzosi MG, Marchioli R, Raimondi E, Masson S, Urso R, Lucci D, Nicolosi GL, Maggioni AP, Tognoni G. Predictors of mortality in 6975 patients with chronic heart failure in the gissi-hf trial: proposal for a nomogram. Circ Heart Fail 2012;6:31–9. 43. White JV, Ryjewski C. Chronic venous insufficiency. Perspect Vasc Surg Endovasc Ther 2005;17:319–327.